A report from the CDC has an analysis of data from 41 health care systems participating in the PCORnet, the National Patient-Centered Clinical Research Network. The results show lower use of monoclonal antibody treatment among Black, Asian, and Other race and Hispanic patients with positive SARS-CoV-2 test results, relative to White and non-Hispanic patients.
The report can be obtained at Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021 | MMWR (cdc.gov).